Label set for an inhalation device

- Glaxo Group Limited
Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

FIG. 1 is a perspective view of the first embodiment of a label set for an inhalation device shown in an environment of use;

FIG. 2 is a front view thereof;

FIG. 3 is a back view thereof;

FIG. 4 is a perspective view of the second embodiment of a label set for an inhalation device shown in an environment of use;

FIG. 5 is a front view thereof; and,

FIG. 6 is a back view thereof.

The broken lines in the above drawings depict environmental subject matter only and form no part of the claimed design.

Claims

The ornamental design for a label set for an inhalation device, as shown and described.

Referenced Cited
U.S. Patent Documents
D24181 April 1895 May
D236657 September 1975 Reeves
4696706 September 29, 1987 Griffin
4748976 June 7, 1988 Cali
5172936 December 22, 1992 Sullivan
D355029 January 31, 1995 Kinneir et al.
D417732 December 14, 1999 Dagsland et al.
D452910 January 8, 2002 Braithwaite et al.
D456505 April 30, 2002 Wolf et al.
D460173 July 9, 2002 Harrison
D477665 July 22, 2003 Myrman et al.
6670009 December 30, 2003 Voss
D484985 January 6, 2004 Takizawa et al.
D490103 May 18, 2004 Rangel
D490932 June 1, 2004 Mammone
6958691 October 25, 2005 Anderson
D518171 March 28, 2006 Anderson et al.
D518376 April 4, 2006 Floyd et al.
D519239 April 18, 2006 Katagiri
D527816 September 5, 2006 Nishibayashi et al.
7249687 July 31, 2007 Anderson
D555206 November 13, 2007 Collins et al.
D557799 December 18, 2007 Greenhalgh et al.
D559107 January 8, 2008 Bates et al.
D560793 January 29, 2008 Pearl et al.
D568744 May 13, 2008 Weber
D569967 May 27, 2008 Pearl et al.
D576724 September 9, 2008 Jensen et al.
7424888 September 16, 2008 Harvey et al.
7434579 October 14, 2008 Young et al.
D594336 June 16, 2009 Alder
D603269 November 3, 2009 Miller
D610621 February 23, 2010 Harris
D613799 April 13, 2010 Clemons et al.
D613848 April 13, 2010 Harvey et al.
D614024 April 20, 2010 Eason et al.
D617206 June 8, 2010 Shaw et al.
D621262 August 10, 2010 Matsumura et al.
D623054 September 7, 2010 Eason et al.
D629308 December 21, 2010 Marotti
D636073 April 12, 2011 White et al.
D637280 May 3, 2011 Harvey et al.
D637281 May 3, 2011 Harvey et al.
D637282 May 3, 2011 Harvey et al.
7964228 June 21, 2011 Milliorn
D642332 July 26, 2011 Kim
D650678 December 20, 2011 Marotti
D659236 May 8, 2012 Bobjer et al.
D663478 July 10, 2012 Tousley
D667105 September 11, 2012 Zuyderhoudt
8281929 October 9, 2012 Franks
D677377 March 5, 2013 White
D684254 June 11, 2013 Zuyderhoudt
D691051 October 8, 2013 Murphy et al.
D692953 November 5, 2013 Biesel
D694633 December 3, 2013 Murphy et al.
D699897 February 18, 2014 Lara
D720014 December 23, 2014 Erenguc et al.
D736096 August 11, 2015 Marotti et al.
D737378 August 25, 2015 Marcinkowski
D746378 December 29, 2015 Manowski
D748988 February 9, 2016 Marotti et al.
D751403 March 15, 2016 Phillips
D759163 June 14, 2016 Manowski
D768241 October 4, 2016 Bull et al.
D777904 January 31, 2017 Van Sickle et al.
D841740 February 26, 2019 Bull et al.
D869638 December 10, 2019 Shinichi
D938521 December 14, 2021 Bull et al.
20020053344 May 9, 2002 Davies et al.
20050081851 April 21, 2005 Young et al.
20050268909 December 8, 2005 Bonney et al.
20060185672 August 24, 2006 Pinon et al.
20060196504 September 7, 2006 Augustyn et al.
20070181123 August 9, 2007 Houzego
20080196718 August 21, 2008 Connell et al.
20090320338 December 31, 2009 David
20120152245 June 21, 2012 Rolfs et al.
20120291782 November 22, 2012 Bowman et al.
20130072894 March 21, 2013 Langley
20130152927 June 20, 2013 Baillet et al.
20130306071 November 21, 2013 Bunch et al.
20140083422 March 27, 2014 Arvidsson et al.
20140137864 May 22, 2014 Striebig et al.
Foreign Patent Documents
300837666 October 2008 CN
0224263 March 2002 WO
02053216 July 2002 WO
03024514 March 2003 WO
03061743 July 2003 WO
03090825 November 2003 WO
03095010 November 2003 WO
2004011070 February 2004 WO
2005002654 January 2005 WO
2005014089 February 2005 WO
2005037353 April 2005 WO
2005079727 September 2005 WO
2006018261 February 2006 WO
2006066908 June 2006 WO
2007012871 February 2007 WO
2007068896 June 2007 WO
2007068900 June 2007 WO
Other references
  • GSKInhaler[online], Sec.gov[retrieved on Nov. 3, 2014], Retrieved from the Internet:<URL:http://www.sec.gov/Archives/edgar/data/1080014/000110465913068581/a13-20084_2ex99d3.htm>.
  • Breo Label[online], TinEye.com[retrieved on Nov. 6, 2014], Retrieved from the Internet:<URL:http://www.tineye.com/search/7f4dd4c0da7206863ae8937221a43d4fda9c74/?pluginver=chrom-1.1.4>.
  • “Center for Drug Evaluation and Research”, Application No. 204275Orig1s000; Highlights of Prescribing Information: Breo Ellipta (fluticasone furoate and vilanterol inhalation powder); Reference ID:3306791.
  • Powder Inhalers; Design No. 000014782-0001; Application Date: Apr. 1, 2003; Applicat Identifier 50559.
  • Powder Inhalers; Design No. 000014782-0002; Application Date: Apr. 1, 2003; Applicat Identifier 50559.
  • Powder Inhalers; Design No. 000014782-0003; Application Date: Apr. 1, 2003; Applicat Identifier 50559.
  • Powder Inhalers; Design No. 000014782-0004; Application Date: Apr. 1, 2003; Applicat Identifier 50559.
  • Powder Inhalers; Design No. 000014782-0005; Application Date: Apr. 1, 2003; Applicat Identifier 50559.
  • Powder Inhalers; Design No. 000014782-0006; Application Date: Apr. 1, 2003; Applicat Identifier 50559.
Patent History
Patent number: D1104149
Type: Grant
Filed: Nov 4, 2021
Date of Patent: Dec 2, 2025
Assignee: Glaxo Group Limited
Inventors: William Bull (Ware), Richard Adams (Research Triangle Park, NC), Philippe Ragot (Research Triangle Park, NC), Carlo Brunelli (Verona), Lisa Olivieri (Verona), Jeffrey Schons (Research Triangle Park, NC), Alec Johnson (Barnard Castle)
Primary Examiner: Catherine Ho
Application Number: 29/814,200
Classifications
Current U.S. Class: Label Or Tag (6) (D20/22)